Clinical Trials Browser

Advanced Pancreatic Cancer

Nasopharyngeal Neoplasms

Advanced Solid Tumor

Rectal Neoplasms

Carcinoma, Hepatocellular

Nasopharyngeal Carcinoma

Colorectal Neoplasms

Advanced Malignant Neoplasm

Lymphoma, Large B-Cell, Diffuse

Colorectal Neoplasms

Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Gynecological Cancer

Carcinoma, Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Stomach Neoplasms

Osteosarcoma

Squamous Cell Carcinoma of Head and Neck

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma

Pancreatic Adenocarcinoma Metastatic

Lung Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

Neoplasm Metastasis, Paraganglioma, Extra-Adrenal, Pheochromocytoma

Carcinoma, Hepatocellular

Advanced Solid Tumor

Breast Neoplasms

Nasopharyngeal Carcinoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Neoplasms by Histologic Type, Lymphoma, Large B-Cell, Diffuse

Esophageal Squamous Cell Carcinoma

Thyroid Neoplasms

Clinical Trials

Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

ALTER-HN005

Clinical Studies for the Treatment of Advanced Solid Tumors

SPARC

JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure

A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

LARC-nCR01

TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.

A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL

Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC

PAAG

Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer

A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.

ALTER-GO-020

EXPLORING

PROMIS

Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC

Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer

RCT-PAAG

A Single Center, Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody

A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma

The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment

Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors

To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma

Disitamab Vedotin(RC48) Combined With Penpulimab(AK105) for Neoadjuvant Treatment of HER2-low Breast Cancer

Penpulimab in Maintenance Therapy in Lymphoma

TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancer

A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma

Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)

ALTER-C003

Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL

Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Anlotinib or Penpulimab in Combination With RAI for DTC